http://www.world-science.net/othernews/090420_personalized
Scanned by: Alvis Brigisover 2 years ago
A private company’s “genetic profiles” of individual cancer patients in a study helped create personalized treatments that helped them survive longer, according to researchers.
The study, released jointly by healthcare organizations in the Phoenix, Ariz. area, was presented April 19 at the annual meeting of the American Association for Cancer Research in Denver by Daniel Von Hoff, physician-in-chief of the Phoenix-based Translational Genomics Research Institute.
The study included 66 patients at nine centers across the United States who had previously suffered tumor growth while receiving as many as two to six prior treatments, including chemotherapy. But after molecular profiling identified precise targets, new treatments were administered that resulted in patients experiencing significant periods of time when there was no progression of their cancer, the researchers said.